Form DRSLTR - Correspondence Related to Draft Registration Statement:
SEC Accession No. 0000950123-23-006930
Filing Date
2023-08-08
Accepted
2023-08-08 21:36:31
Documents
3

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRSLTR 19326
2 GRAPHIC g241143g23o55.jpg GRAPHIC 9486
3 GRAPHIC g241143g54o40.jpg GRAPHIC 10616
  Complete submission text file 0000950123-23-006930.txt   37480
Mailing Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY, SUITE 200 WATERTOWN MA 02472 (857) 760-0900
Neumora Therapeutics, Inc. (Filer) CIK: 0001885522 (see all company filings)

EIN.: 844367680 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRSLTR
SIC: 2836 Biological Products, (No Diagnostic Substances)